Anzeige
Mehr »
Donnerstag, 18.09.2025 - Börsentäglich über 12.000 News
Die Ethereum-Vorreiter: Wie Republic Technologies die Infrastruktur der Zukunft aufbaut
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2P8F1 | ISIN: CA74764Y2050 | Ticker-Symbol: 0K91
Tradegate
18.09.25 | 18:46
16,100 Euro
+7,33 % +1,100
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
QUANTUM BIOPHARMA LTD Chart 1 Jahr
5-Tage-Chart
QUANTUM BIOPHARMA LTD 5-Tage-Chart
RealtimeGeldBriefZeit
16,30016,80019:11
16,30016,80019:08

Aktuelle News zur QUANTUM BIOPHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
14:42Health Canada grants product license for Quantum BioPharma's Qlarity7
14:34Health Canada erteilt Produktlizenz für Qlarity von Quantum BioPharma13
14:12Health Canada Grants Quantum BioPharma a Product License for Its Innovative Product, Qlarity, that Enhances Energy, and Promotes Metabolism, Mental Alertness and Cognitive Performance1
14:10Quantum Biopharma Ltd. - 6-K, Report of foreign issuer7
FrQuantum Biopharma Ltd: Quantum Biopharma licensee to hold webinar Sept. 1613
10.09.Kingswood Capital Partners Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$45 Price Target191TORONTO, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated...
► Artikel lesen
10.09.Quantum Biopharma Ltd. - 6-K, Report of foreign issuer2
21.08.Quantum Biopharma Ltd: Quantum Biopharma board OKs $26K (U.S.) debt settlement11
QUANTUM BIOPHARMA Aktie jetzt für 0€ handeln
21.08.Quantum BioPharma Announces Corporate Updates202TORONTO, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated...
► Artikel lesen
21.08.Quantum Biopharma Ltd. - 6-K, Report of foreign issuer3
12.08.Quantum Biopharma Ltd: Quantum Biopharma to seek shareholder OK for financing9
12.08.Quantum BioPharma to seek shareholder approval for private placement4
12.08.Quantum BioPharma Ltd.: Quantum BioPharma Announces Update to Previously Announced Private Placement486Toronto, Ontario--(Newsfile Corp. - August 11, 2025) - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE: 0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to...
► Artikel lesen
11.08.Quantum Biopharma Ltd: Quantum Biopharma signs agreement with manufacturer4
11.08.Quantum BioPharma schließt Produktionsvertrag für MS-Medikament in oraler Form6
11.08.Quantum BioPharma signs manufacturing deal for MS drug oral form10
11.08.Quantum BioPharma Signs Agreement to Manufacture Oral Drug Formulation of its Potential Breakthrough Drug Lucid-21-302 (Lucid-MS) for Use in its Upcoming Phase 2 Multiple Sclerosis Trial173TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated...
► Artikel lesen
08.08.Quantum Biopharma Ltd: Quantum Biopharma talks PET tracer in MS study4
08.08.Quantum BioPharma Announces Very Promising Results from the Massachusetts General Hospital Scientists on the Novel Positron Emission Tomography (PET) Tracer Used to Detect and Monitor Demyelination in Multiple Sclerosis Patients8
08.08.Quantum Biopharma Ltd. - 6-K, Report of foreign issuer3
Weiter >>
147 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,4